Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer
- PMID: 14551340
- DOI: 10.1056/NEJMe038174
Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer
Comment in
-
Letrozole in breast cancer.N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30. N Engl J Med. 2004. PMID: 14971057 No abstract available.
-
Letrozole in breast cancer.N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30. N Engl J Med. 2004. PMID: 14971059 No abstract available.
Comment on
-
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.N Engl J Med. 2003 Nov 6;349(19):1793-802. doi: 10.1056/NEJMoa032312. Epub 2003 Oct 9. N Engl J Med. 2003. PMID: 14551341 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical